Advertisement
Screener

ROIVANT SCIENCES LTD. (ROIV) ROA

ROIVANT SCIENCES LTD. (ROIV) ROA

  • 2026-06-30: ROA -5.02%.
  • 2026-03-31: ROA -5.25%.
  • 2025-12-31: ROA -15.49%.
  • 2025-09-30: ROA -7.39%.

Complete source-backed roa history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-5.02%
2026-03-31-5.25%
2025-12-31-15.49%
2025-09-30-7.39%
2025-06-30-9.75%
2025-03-31-3.16%
2024-12-31-2.01%
2024-09-3077.51%
2024-06-3072.90%
2024-03-3160.21%
2023-12-3161.08%
2023-09-30-47.53%
2023-06-30-45.35%
2023-03-31-42.23%
2022-12-31-56.54%
2022-09-30-53.17%
2022-06-30-42.10%
2022-03-31-32.70%
2021-12-31-38.75%
2021-09-30-34.20%
2021-06-30-36.18%
2021-03-31-31.25%

Annual ROA

DateROA
2026-03-31-5.25%
2025-03-31-3.16%
2024-03-3160.21%
2023-03-31-42.23%
2022-03-31-32.70%
2021-03-31-31.25%

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Zoetis Inc. (ZTS)United States$29.045B11.38
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10